Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

Nav

General Info

Geography

United Kingdom (GBR)

Time period covered

01/2002 - 12/2007

Data type

Scientific literature

Keywords

Cancers, Cervix uteri cancer, HPV, HPV vaccines, Survival

Citation

Authors

Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER

Journal

Cost Eff Resour Alloc

Volume

Pages

Publication year

2008

Suggested citation

Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER. Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis. Cost Eff Resour Alloc. 2008; 6: 4.

DOI

10.1186/1478-7547-6-4

PMID

18279515

GHDx Entry last modified on: Jan 31, 2023

Header sites

Search form

Main menu

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

Nav